{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:52:14Z","timestamp":1789660334431,"version":"4.0.1"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T00:00:00Z","timestamp":1339200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s12010-012-9755-z","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T05:28:48Z","timestamp":1339133328000},"page":"2144-2159","source":"Crossref","is-referenced-by-count":54,"title":["l-Asparaginase as Potent Anti-leukemic Agent and Its Significance of Having Reduced Glutaminase Side Activity for Better treatment of Acute Lymphoblastic Leukaemia"],"prefix":"10.1007","volume":"167","author":[{"given":"L. N.","family":"Ramya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Doble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P. B.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. K.","family":"Pulicherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,9]]},"reference":[{"key":"9755_CR1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM198411083111905","volume":"311","author":"AD Jacobs","year":"1984","unstructured":"Jacobs, A. D., & Gale, R. P. (1984). Recent advances in the biology and treatment of acute lymphoblastic leukaemia in adults. The New England Journal of Medicine, 311, 1219.","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"9755_CR2","first-page":"683","volume":"60","author":"D Pinkel","year":"1987","unstructured":"Pinkel, D. (1987). Curing children of leukaemia. Cancer, 60(1), 683.","journal-title":"Cancer"},{"key":"9755_CR3","unstructured":"Ries, L. A., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L., Bunin, G. R. (eds) (1999). Cancer incidence and survival among children and adolescents: United States SEER Program 1975\u20131995. Bethesda: National Cancer Institute. 13, 335\u2013342."},{"key":"9755_CR4","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","volume":"104","author":"CH Pui","year":"2004","unstructured":"Pui, C. H., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Razzouk, B. I., Howard, S. C., Hudson, M. M., Cheng, C., Kun, L. E., Raimondi, S. C., Behm, F. G., Downing, J. R., Relling, M. V., & William, E. (2004). Improved outcome for children with acute lymphoblastic leukaemia: results of total therapy study XIIIB at St Jude Children\u2019s Research Hospital. Blood, 104, 2690\u20132696.","journal-title":"Blood"},{"key":"9755_CR5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","volume":"97","author":"LB Silverman","year":"2001","unstructured":"Silverman, L. B., Gelber, R. D., Dalton, V. K., Assenlin, B. L., Barr, R. D., Clavell, L. A., Hurwitz, C. A., Moqhrabi, A., Samson Assenlin, B. L., Barr, R. D., Clavell, L. A., Hurwitz, C. A., Moqhrabi, A., Samson, Y., Schorin, M. A., Arkin, S., Declerck, L., Cohen, H. J., & Sallan, S. E. (2001). Improved outcome for children with acute lymphoblastic leukaemia: results of Dana\u2013Farber consortium protocol 91\u201301. Blood, 97, 1211\u20131218.","journal-title":"Blood"},{"key":"9755_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2003.10.032","volume":"21","author":"B Burger","year":"2003","unstructured":"Burger, B., Zimmermann, M., Mann, G., Kuhl, J., Loning, L., Riehm, H., Reiter, A., & Schrappe, M. (2003). Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukaemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. Journal of Clinical Oncology, 21, 179\u2013181.","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E. L., Link, M., Murphy, S., Puj, C. H., Pullen, J., Reamon, G., Sallan, S. E., Sather, H., Shuster, J., Simon, R., Trigg, M., Tubergen, D., Uckun, F., & Ungerleider, R. (1996). Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukaemia. Journal of Clinical Oncology, 14, 18\u201324 [see comments].","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2005-11-4606","volume":"107","author":"MA Weiss","year":"2006","unstructured":"Weiss, M. A., & Lamanna, N. (2006). In adult ALL, less is now more. Blood, 107, 852\u2013853.","journal-title":"Blood"},{"key":"9755_CR9","first-page":"145","volume-title":"Leukaemia","author":"FD Groves","year":"1996","unstructured":"Groves, F. D., Linet, M. S., & Devesa, S. S. (1996). Epidemiology of leukaemia: Overview of patterns of occurrence. In E. S. Henderson, T. A. Lister, & M. F. Greaves (Eds.), Leukaemia (6th ed., pp. 145\u2013159). Philadelphia: Saunders.","edition":"6"},{"key":"9755_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mpo.2950140317","volume":"14","author":"R Mastrangelo","year":"1986","unstructured":"Mastrangelo, R., Poplack, D., Bleyer, A., Riccardi, R., Sather, H., & D\u2019Angio, G. (1986). Report and recommendations of the Rome Workshop Concerning Poor-Prognosis Acute Lymphoblastic Leukaemia in Children: biologic bases for staging, stratification, and treatment. Medical and Pediatric Oncology, 14, 191\u2013194.","journal-title":"Medical and Pediatric Oncology"},{"key":"9755_CR11","first-page":"122","volume":"12","author":"CM Niemeyer","year":"1985","unstructured":"Niemeyer, C. M., Hitchcock-Bryan, S., & Sallen, S. E. (1985). Comparative analysis of treatment programs for childhood acute lymphoblastic leukaemia. Seminars in Oncology, 12, 122.","journal-title":"Seminars in Oncology"},{"key":"9755_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM198607313150509","volume":"315","author":"AM Mauer","year":"1986","unstructured":"Mauer, A. M. (1986). New directions in the treatment of acute lymphoblastic leukaemia in children. The New England Journal of Medicine, 315, 316.","journal-title":"The New England Journal of Medicine"},{"key":"9755_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mpo.2950140305","volume":"14","author":"D Hammond","year":"1986","unstructured":"Hammond, D., Sather, H., Nesbit, M., Miller, D., Coccia, P., Bleyer, A., Lukens, J., & Siegel, S. (1986). Analysis of prognostic factors in acute lymphoblastic leukaemia. Medical and Pediatric Oncology, 14, 124.","journal-title":"Medical and Pediatric Oncology"},{"key":"9755_CR14","first-page":"12","volume":"24","author":"OK Rivera","year":"1987","unstructured":"Rivera, O. K., & Mauer, A. M. (1987). Controversies in the management of childhood acute lymphoblastic leukaemia: treatment intensification, CNS leukaemia and prognostic factors. Seminars in Hematology, 24, 12.","journal-title":"Seminars in Hematology"},{"key":"9755_CR15","unstructured":"Riehm, H., Feickert, H. I., Schrappe, M., Henze, G., & Schelbong. (1987). From the BFM Study Group: Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis. Haematol Blood Transfus, 30, 139\u2013146."},{"key":"9755_CR16","first-page":"27","volume":"24","author":"D Hoebzer","year":"1987","unstructured":"Hoebzer, D., & Gale, R. P. (1987). Acute lymphoblastic leukaemia in adults: recent progress, future directions. Seminars in Hematology, 24, 27.","journal-title":"Seminars in Hematology"},{"key":"9755_CR17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/aje\/kwg210","volume":"158","author":"LL Hjalgrim","year":"2003","unstructured":"Hjalgrim, L. L., Westergaard, T., Rostgaard, K., Melbyei, M., Hjalgrim, H., Engels, E. A., et al. (2003). Birth weight as a risk factor for childhood leukaemia: a meta-analysis of 18 epidemiologic studies. American Journal of Epidemiology, 158, 724\u2013735.","journal-title":"American Journal of Epidemiology"},{"key":"9755_CR18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1054\/bjoc.2000.1376","volume":"83","author":"A Ahlbom","year":"2000","unstructured":"Ahlbom, A., Day, N., & Feychting, M. (2000). A pooled analysis of magnetic fields and childhood leukaemia. British Journal of Cancer, 83, 692\u2013698.","journal-title":"British Journal of Cancer"},{"key":"9755_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1081\/CNV-46402","volume":"23","author":"PA Buer","year":"2005","unstructured":"Buer, P. A., Kwan, M. L., Reynolds, P., & Urayama, K. Y. (2005). Environmental and genetic risk factors for childhood leukaemia: appraising the evidence. Cancer Investigation, 23, 60\u201375.","journal-title":"Cancer Investigation"},{"key":"9755_CR20","first-page":"1102","volume-title":"Hematology of infancy and childhood","author":"FP Li","year":"1993","unstructured":"Li, F. P. (1993). Epidemiology of cancer in childhood. In D. G. Nathan & F. A. Oski (Eds.), Hematology of infancy and childhood (4th ed., p. 1102). Philadelphia: Saunders.","edition":"4"},{"key":"9755_CR21","first-page":"60","volume":"72","author":"VN Mukhin","year":"2000","unstructured":"Mukhin, V. N. (2000). Acute leukaemia in adults: morbidity in Donetsk region of Ukraine before and after Chernobyl\u2019s accident. Terapevticheski\u012d Arkhiv, 72, 60\u201362.","journal-title":"Terapevticheski\u012d Arkhiv"},{"key":"9755_CR22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/bmj.2.5474.1327","volume":"5474","author":"WM Brown","year":"1965","unstructured":"Brown, W. M., & Doll, R. (1965). Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. British Medical Journal, 5474, 1327\u20131332.","journal-title":"British Medical Journal"},{"key":"9755_CR23","first-page":"349","volume":"7","author":"MF Greaves","year":"1993","unstructured":"Greaves, M. F., & Alexander, F. E. (1993). An infectious etiology for common acute lymphoblastic leukaemia in childhood? Leukaemia, 7, 349\u2013360.","journal-title":"Leukaemia"},{"key":"9755_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(87)90556-3","volume":"49","author":"L Lombardi","year":"1987","unstructured":"Lombardi, L., Newcomb, E. W., & Dalla-Favera, R. (1987). Pathogenesis of Burkett\u2019s lymphoma: expression of an activated c-myc oncogene causes the tumorogenic conversion of EBV-infected B lymphoblasts. Cell, 49, 161\u2013170.","journal-title":"Cell"},{"key":"9755_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/07420528909056930","volume":"6","author":"AA Meltzer","year":"1989","unstructured":"Meltzer, A. A., Spitz, M. R., Johnson, C. C., & Culbert, S. J. (1989). Season-of birth and acute leukaemia of infancy. Chronobiology International, 6, 285\u2013289.","journal-title":"Chronobiology International"},{"key":"9755_CR26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s002770050539","volume":"78","author":"TT Timonen","year":"1999","unstructured":"Timonen, T. T. (1999). A hypothesis concerning deficiency of sunlight, cold temperature, and influenza epidemics associated with the onset of acute lymphoblastic leukaemia in northern Finland. Annals of Hematology, 78, 408\u2013414.","journal-title":"Annals of Hematology"},{"key":"9755_CR27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/13813452209145156","volume":"19","author":"A Clementi","year":"1922","unstructured":"Clementi, A. (1922). Desamidation enzymatique de l\u2019 l-Asparagine. Archives Internationales de Physiologie, 19, 369.","journal-title":"Archives Internationales de Physiologie"},{"key":"9755_CR28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/1911114a0","volume":"191","author":"JD Broome","year":"1961","unstructured":"Broome, J. D. (1961). Evidence that the l-Asparaginase activity of guinea pig serum is responsible for its anti-lymphoma effects. Nature, 191, 1114\u20131115.","journal-title":"Nature"},{"key":"9755_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.118.1.99","volume":"118","author":"JD Broome","year":"1963","unstructured":"Broome, J. D. (1963). Evidence that the l-Asparaginase of guinea pig serum is responsible for its antilymphoma effects. I and II. The Journal of Experimental Medicine, 118, 99.","journal-title":"The Journal of Experimental Medicine"},{"key":"9755_CR30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.98.6.565","volume":"98","author":"JG Kidd","year":"1953","unstructured":"Kidd, J. G. (1953). Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum: I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum or rabbit serum. The Journal of Experimental Medicine, 98, 565\u2013582.","journal-title":"The Journal of Experimental Medicine"},{"key":"9755_CR31","first-page":"185","volume":"39","author":"JJ Winston","year":"1973","unstructured":"Winston, J. J., & Yellin, T. (1973). l-Asparaginase: a review. Advances in Enzymology, 39, 185\u2013248.","journal-title":"Advances in Enzymology"},{"key":"9755_CR32","first-page":"2619","volume":"27","author":"HF Oettgen","year":"1967","unstructured":"Oettgen, H. F., Old, L. J., & Boyse, E. A. (1967). Inhibition of leukaemias in man by l-asparaginase. Cancer Research, 27, 2619\u20132631.","journal-title":"Cancer Research"},{"key":"9755_CR33","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1967.03130220070012","volume":"202","author":"JM Hill","year":"1967","unstructured":"Hill, J. M., Roberts, J., Loeb, E., MacLellan, H. A., & Hill, R. W. (1967). l-Asparaginase therapy for leukaemia and other malignant neoplasms. Journal of the American Medical Association, 202, 882.","journal-title":"Journal of the American Medical Association"},{"key":"9755_CR34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj1260361","volume":"126","author":"K Cammack","year":"1972","unstructured":"Cammack, K., Marlborough, D., & Miller, D. (1972). Physical properties and subunit structure of l-asparaginase isolated from Erwinia carotovora. Biochemical Journal, 126, 361.","journal-title":"Biochemical Journal"},{"key":"9755_CR35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(68)90977-X","volume":"2","author":"HE Wade","year":"1968","unstructured":"Wade, H. E., Ellsworth, R., Herbert, E., Keppie, J., & Sargeant, K. (1968). A new l-asparaginase with antitumor activity? Lancet, 2, 776\u2013777.","journal-title":"Lancet"},{"key":"9755_CR36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0021-9258(19)45762-1","volume":"247","author":"J Roberts","year":"1972","unstructured":"Roberts, J., Holcenberg, J., & Dolowy, W. (1972). Isolation, crystallization and properties of Achromobacteraceae glutaminase \u2013 asparaginase with antitumor activity. Journal of Biological Chemistry, 247, 84.","journal-title":"Journal of Biological Chemistry"},{"key":"9755_CR37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1139\/o72-157","volume":"50","author":"E Soru","year":"1972","unstructured":"Soru, E., Teodorescu, M., Zaharia, O., Szabados, J., & Rudescu, K. (1972). l-Asparaginase from the BCG strain of Mycobacterium bovis: I. Purification and in vitro immunosuppressive properties. Canadian Journal of Biochemistry, 50, 1149.","journal-title":"Canadian Journal of Biochemistry"},{"key":"9755_CR38","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1128\/AEM.23.6.1163-1164.1972","volume":"23","author":"PJ Dejong","year":"1972","unstructured":"Dejong, P. J. (1972). l-Asparaginase production by Streptomyces griseus. Applied andEnvironmental Microbiology, 23, 1163.","journal-title":"Applied andEnvironmental Microbiology"},{"key":"9755_CR39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0005-2744(73)90112-5","volume":"327","author":"P Jones","year":"1973","unstructured":"Jones, P., Kristiansen, T., & Einarsson, M. (1973). Purification and properties of l-asparaginase from Acinetobacter calcoaeticus. Biochimica et Biophysica Acta, 327, 146.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9755_CR40","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1016\/S0021-9258(19)43338-3","volume":"248","author":"B Lee","year":"1973","unstructured":"Lee, B., & Yang, H. (1973). Crystallographic studies on l-Asparaginase from Proteus vulgaris: I. Preliminary crystal data. Journal of Biological Chemistry, 248, 7620.","journal-title":"Journal of Biological Chemistry"},{"key":"9755_CR41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0005-2795(74)90266-9","volume":"365","author":"H Whelan","year":"1974","unstructured":"Whelan, H., & Wriston, J. (1974). Purification and properties of l-asparaginase from Serratia marcescens. Biochimica et Biophysica Acta, 365, 212.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"9755_CR42","first-page":"325","volume":"134","author":"SA Mustafa","year":"1979","unstructured":"Mustafa, S. A., & Salama, M. S. (1979). l-Asparaginase producing Streptomyces from soil of Kuwait. Zentralbel Bakterol Naturwiss, 134(4), 325\u2013334.","journal-title":"Zentralbel Bakterol Naturwiss"},{"issue":"3","key":"9755_CR43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12088-008-0018-1","volume":"48","author":"KJP Narayana","year":"2007","unstructured":"Narayana, K. J. P., Kumar, K. G., & Vijayalakshmi, M. (2007). l-Asparaginase production by Streptomyces albidoflavus. Indian Journal of Microbiology, 48(3), 331\u2013336.","journal-title":"Indian Journal of Microbiology"},{"key":"9755_CR44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000459338","volume":"17","author":"W Mathews","year":"1974","unstructured":"Mathews, W., & Brown, H. (1974). Isolation of two l-asparaginases from guinea pig liver. Enzyme, 17, 276.","journal-title":"Enzyme"},{"key":"9755_CR45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.pa.10.040170.002225","volume":"10","author":"DA Cooney","year":"1970","unstructured":"Cooney, D. A., & Handschumacher, R. E. (1970). Evaluation of l-Asparagine metabolism. Annual Review of Pharmacology, 10, 421.","journal-title":"Annual Review of Pharmacology"},{"key":"9755_CR46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00023386","volume":"19","author":"TJ Lough","year":"1992","unstructured":"Lough, T. J., Reddington, B. D., Grant, M. R., Hill, D. F., Reynolds, P. H. S., & Farnden, K. J. F. (1992). The isolation and characterization of a c DNA clone encoding l-asparaginase from developing seeds of lupin [Lupinus arboreus). Plant Molecular Biology, 19, 391\u2013399.","journal-title":"Plant Molecular Biology"},{"key":"9755_CR47","first-page":"617","volume":"52","author":"RH Adamson","year":"1968","unstructured":"Adamson, R. H., & Fabro, S. (1968). Antitumor activity and other biologic properties of l-asparaginase \u2013 review. Cancer Chemotherapy, 52, 617.","journal-title":"Cancer Chemotherapy"},{"key":"9755_CR48","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0031-9422(00)97967-6","volume":"28","author":"K Siechiechowicz","year":"1989","unstructured":"Siechiechowicz, K., & Ireland, R. (1989). Isolation and properties of an asparaginase from leaves of Pisum sativum. Phytochemistry, 28, 2275.","journal-title":"Phytochemistry"},{"key":"9755_CR49","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1073\/pnas.56.5.1516","volume":"56","author":"JH Schwartz","year":"1966","unstructured":"Schwartz, J. H., Reeves, J. Y., & Broome, J. D. (1966). Two l-Asparaginases from E. coli and their action against tumours. Proceedings of the Natlional Academy Sciences USA, 56, 1516\u20131519 [PubMed: 5339624].","journal-title":"Proceedings of the Natlional Academy Sciences USA"},{"key":"9755_CR50","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/S0021-9258(18)95875-8","volume":"242","author":"H Cedar","year":"1967","unstructured":"Cedar, H., & Schwartz, J. H. (1967). Localization of the two l-asparaginases in anaerobically grown E. coli. Journal of Biological Chemistry, 242, 3753\u20133755 [PubMed: 4962587].","journal-title":"Journal of Biological Chemistry"},{"key":"9755_CR51","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/JB.96.6.2043-2048.1968","volume":"96","author":"H Cedar","year":"1968","unstructured":"Cedar, H., & Schwartz, J. H. (1968). Production of l-Asparaginase II by E. coli. Journal of Bacteriology, 96, 2043\u20132048 [PubMed: 4881701].","journal-title":"Journal of Bacteriology"},{"key":"9755_CR52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JB.118.1.231-241.1974","volume":"118","author":"RC Willis","year":"1974","unstructured":"Willis, R. C., & Woolfolk, C. A. (1974). l-Asparagine utilization in E. coli. Journal of Bacteriology, 118, 231\u2013241 [PubMed: 4595199].","journal-title":"Journal of Bacteriology"},{"key":"9755_CR53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/JB.154.1.513-515.1983","volume":"154","author":"TD Casale","year":"1983","unstructured":"Casale, T. D., Sollitti, P., & Chesney, R. H. (1983). Cytoplasmic l-asparaginase: isolation of a defective strain and mapping of ans A. Journal of Bacteriology, 154, 513\u2013515 [PubMed: 6339481].","journal-title":"Journal of Bacteriology"},{"key":"9755_CR54","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/jb.172.3.1491-1498.1990","volume":"172","author":"MP Jennings","year":"1990","unstructured":"Jennings, M. P., & Beacham, I. R. (1990). Analysis of the E. coli gene encoding l-asparaginase II, ans B, and its regulation by cyclic AMP receptor and FNR proteins. Journal of Bacteriology, 172, 1491\u20131498 [PubMed: 2407723].","journal-title":"Journal of Bacteriology"},{"key":"9755_CR55","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1999.17.3.818","volume":"17","author":"C-H Pui","year":"1999","unstructured":"Pui, C.-H., Boyett, J. M., Relling, M. V., Harrison, P. L., Rivera, G. K., Behm, F. G., Sandlund, J. T., Riberio, R. C., Rubnitz, J. E., Gajjar, A., & Evans, W. E. (1999). Sex differences in prognosis in children with acute lymphoblastic. Journal of Clinical Oncology, 17, 818.","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR56","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","volume":"2","author":"CH Pui","year":"2001","unstructured":"Pui, C. H., Campana, D., & Evans, W. E. (2001). Childhood acute lymphoblastic leukaemia \u2014 current status and future perspectives. The Lancet Oncology, 2, 597\u2013607.","journal-title":"The Lancet Oncology"},{"key":"9755_CR57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-1119(89)90312-0","volume":"78","author":"PG Jerlstrom","year":"1989","unstructured":"Jerlstrom, P. G., Bezjak, D. A., Jennings, M. P., & Beacham, I. R. (1989). Structure and expression in E. coli K-12 of the l-Asparaginase I-encoding ans A gene and its flanking regions. Gene, 78, 37\u201346.","journal-title":"Gene"},{"key":"9755_CR58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-5793(91)80723-G","volume":"285","author":"E Harms","year":"1991","unstructured":"Harms, E., Wehner, A., Aung, H. P., & Rohm, K. H. (1991). A catalytic role for threonine-12 of E. coli asparaginase II as established by site-directed mutagenesis. FEBS Letters, 285, 55\u201358 [PubMed: 1906013].","journal-title":"FEBS Letters"},{"key":"9755_CR59","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/protein\/5.8.785","volume":"5","author":"C Derst","year":"1992","unstructured":"Derst, C., Henseling, J., & Rohm, K. H. (1992). Probing the role of threonine and serine residues of E. coli asparaginase II by site-specific mutagenesis. Protein Engineering, 5, 785\u2013789 [PubMed: 1287659].","journal-title":"Protein Engineering"},{"key":"9755_CR60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1432-1033.1992.tb17210.x","volume":"208","author":"A Wehner","year":"1992","unstructured":"Wehner, A., Harms, E., Jennings, M. P., Beacham, I. R., Derst, C., Bast, P., & Rohm, K. H. (1992). Site-specific mutagenesis of E. coli asparaginase II. None of the three histidine residues is required for catalysis. European Journal of Biochemistry, 208, 475\u2013480.","journal-title":"European Journal of Biochemistry"},{"key":"9755_CR61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-5793(96)00660-6","volume":"390","author":"GJ Palm","year":"1996","unstructured":"Palm, G. J., Lubkowski, J., Derst, C., Schleper, S., Rohm, K. H., & Wlodawer, A. (1996). A covalently bound catalytic intermediate in E. coli asparaginase: crystal structure of a Thr-89-Val mutant. FEBS Letters, 390, 211\u2013216 [PubMed: 8706862].","journal-title":"FEBS Letters"},{"key":"9755_CR62","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1073\/pnas.90.4.1474","volume":"90","author":"AL Swain","year":"1993","unstructured":"Swain, A. L., Jaskolski, M., Housset, D., Rao, J. K., & Wlodawer, A. (1993). Crystal structure of E. coli l-Asparaginase, an enzyme used in cancer therapy. Proceedings of the Natlional Academy Sciences USA, 90, 1474\u20131478 [PubMed: 8434007].","journal-title":"Proceedings of the Natlional Academy Sciences USA"},{"issue":"3","key":"9755_CR63","doi-asserted-by":"crossref","first-page":"807","DOI":"10.18388\/abp.2000_3998","volume":"47","author":"M Kozak","year":"2000","unstructured":"Kozak, M., Jasloski, M., & Rohm, K. H. (2000). Preliminary crystallographic studies of 425F mutant of periplasmic Escherichia coli l-asparaginase. Acta Biochimica Polonica, 47(3), 807\u2013814.","journal-title":"Acta Biochimica Polonica"},{"key":"9755_CR64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-4838(00)00179-5","volume":"1481","author":"HP Aung","year":"2000","unstructured":"Aung, H. P., Bocola, M., Schleper, S., & Rohm, K. H. (2000). Dynamics of a mobile loop at the active site of Escherichia coli asparaginase. Biochimica et Biophysica Acta, 1481, 349\u2013359.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9755_CR65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1107\/S0907444900020175","volume":"57","author":"M Jaskolski","year":"2001","unstructured":"Jaskolski, M., Kozak, M., Lubkowski, J., Palm, G., & Wlodawer, A. (2001). Structures of two highly homologous bacterial l-asparaginases: a case of enantiomorphic space groups. Acta Crystallographica. Section D, Biological Crystallography, 57, 369\u2013377.","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"9755_CR66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.18388\/abp.2002_3810","volume":"49","author":"M Kozak","year":"2002","unstructured":"Kozak, M., & Jurga, S. (2002). A comparison between the crystal and solution structures of E. coli asparaginase II. Acta Biochimica Polonica, 49, 509\u2013513 [PubMed: 12362993].","journal-title":"Acta Biochimica Polonica"},{"key":"9755_CR67","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1107\/S0907444902021200","volume":"59","author":"M Sanches","year":"2003","unstructured":"Sanches, M., Barbosa, J. A., de Oliveira, R. T., Abrahao, N. J., & Polikarpov, I. (2003). Structural comparison of E. coli l-asparaginase in two monoclinic space groups. Acta Crystallographica. Section D, Biological Crystallography, 59, 416\u2013422 [PubMed: 12595697].","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"9755_CR68","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0021-9258(19)45610-X","volume":"247","author":"JB Howard","year":"1972","unstructured":"Howard, J. B., & Carpenter, F. H. (1972). l-Asparaginase from Erwinia carotovora. Substrate specificity and enzymatic properties. Journal of Biological Chemistry, 247, 1020\u20131030.","journal-title":"Journal of Biological Chemistry"},{"key":"9755_CR69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-5793(93)80943-O","volume":"328","author":"M Miller","year":"1993","unstructured":"Miller, M., Rao, J. K., Wlodawer, A., & Gribskov, M. R. (1993). A left-handed crossover involved in amidohydrolase catalysis. Crystal structure of Erwinia chrysanthemi l-asparaginase with bound l-aspartate. FEBS Letters, 328, 275\u2013279.","journal-title":"FEBS Letters"},{"key":"9755_CR70","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/bi0029595","volume":"40","author":"K Aghaiypour","year":"2001","unstructured":"Aghaiypour, K., Wlodawer, A., & Lubkowski, J. (2001). Structural basis for the activity and substrate specificity of Erwinia chrysanthemi l-asparaginase. Biochemistry, 40, 5655\u20135664.","journal-title":"Biochemistry"},{"key":"9755_CR71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1107\/S0907444902019443","volume":"59","author":"J Lubkowski","year":"2003","unstructured":"Lubkowski, J., Dauter, M., Aghaiypour, K., Wlodawer, A., & Dauter, Z. (2003). Atomic resolution structure of Erwinia chrysanthemi l-asparaginase. Acta Crystallographica. Section D, Biological Crystallography, 59, 84\u201392.","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"9755_CR72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1432-1033.1996.0201t.x","volume":"241","author":"J Lubkowski","year":"1996","unstructured":"Lubkowski, J., Palm, G. J., Gilliland, G. L., Derst, C., R\u00f6hm, K. H., & Wlodawer, A. (1996). Crystal structure and amino acid sequence of Wolinella succinogenes l-asparaginase. European Journal of Biochemistry, 241, 201\u2013207.","journal-title":"European Journal of Biochemistry"},{"key":"9755_CR73","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/bi00200a005","volume":"33","author":"J Lubkowski","year":"1994","unstructured":"Lubkowski, J., Wlodawer, A., Ammon, H. L., Copeland, T. D., & Swain, A. L. (1994). Structural characterization of Pseudomonas 7A glutaminase\u2013asparaginase. Biochemistry, 33, 10257\u201310265.","journal-title":"Biochemistry"},{"key":"9755_CR74","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1107\/S0907444994003446","volume":"50","author":"J Lubkowski","year":"1994","unstructured":"Lubkowski, J., Wlodawer, A., Housset, D., Weber, I. T., Ammon, H. L., Murphy, K. C., & Swain, A. L. (1994). Refined crystal structure of Acinetobacter glutaminasificans glutaminase\u2013asparaginase. Acta Crystallographica. Section D, Biological Crystallography, 50, 826\u2013832.","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"9755_CR75","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/bi991797d","volume":"39","author":"E Ortlund","year":"2000","unstructured":"Ortlund, E., LaCount, M. W., Lewinski, K., & Lebioda, L. (2000). Reactions of Pseudomonas 7A glutaminase\u2013asparaginase with diazo analogues of glutamine and l-Asparagine result in unexpected covalent inhibitions and suggests an unusual catalytic triad Thr\u2013Tyr\u2013Glu. Biochemistry, 39, 1199\u20131204.","journal-title":"Biochemistry"},{"key":"9755_CR76","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.127.6.1055","volume":"127","author":"JD Broome","year":"1968","unstructured":"Broome, J. D. (1968). Studies on the mechanism of tumor inhibition by l-asparaginase: effects of the enzyme on l-Asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in l-Asparagine formation and utilization in asparaginase sensitive and -resistant lymphoma cells. The Journal of Experimental Medicine, 127, 1055\u20131072.","journal-title":"The Journal of Experimental Medicine"},{"key":"9755_CR77","first-page":"367","volume":"44","author":"VI Avramis","year":"2005","unstructured":"Avramis, V. I., & Panosyan, E. H. (2005). Pharmacokinetic\/pharmacodynamic basis for some drug-related side effects. European Journal of Clinical Investigation, 44, 367\u2013393. 1055\u20131072.","journal-title":"European Journal of Clinical Investigation"},{"issue":"6","key":"9755_CR78","first-page":"489","volume":"131","author":"SM Badr El Din","year":"1976","unstructured":"Badr El Din, S. M., & Foda, M. S. (1976). Kinetics and properties of l-glutaminase EC-3.5.1.2 and l-asparaginase EC-3.5.1.1 activities of Pseudomonas ovalis. Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschafliche Abteilung Allgemeine Landwirtschaftliche und Technische. Mikrobiologie, 131(6), 489\u2013496.","journal-title":"Mikrobiologie"},{"issue":"2","key":"9755_CR79","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/JB.125.2.719-727.1976","volume":"125","author":"ML Stern","year":"1976","unstructured":"Stern, M. L., Phillips, A. W., & Gottlieb, A. J. (1976). Physical properties of l-asparaginase from Serratia marcescens. Journal of Bacteriology, 125(2), 719\u2013727.","journal-title":"Journal of Bacteriology"},{"issue":"1","key":"9755_CR80","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/JB.130.1.128-130.1977","volume":"130","author":"GE Jones","year":"1977","unstructured":"Jones, G. E. (1977). Genetic and physiological relationships between l-asparaginase I and l-asparaginase II Saccharomyces cerevisiae. Journal of Bacteriology, 130(1), 128\u2013130.","journal-title":"Journal of Bacteriology"},{"issue":"1","key":"9755_CR81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/JB.147.1.9-12.1981","volume":"147","author":"JH Paul","year":"1981","unstructured":"Paul, J. H., & Cooksey, K. E. (1981). Regulation of l-Asparaginase E.C.-3.5.1.1 in a Chlamydomonas species in response to ambient concentrations of combined nitrogen. Journal of Bacteriology, 147(1), 9\u201312.","journal-title":"Journal of Bacteriology"},{"issue":"5","key":"9755_CR82","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF02818783","volume":"47","author":"B Borkotaky","year":"2002","unstructured":"Borkotaky, B., & Bezbaruah, R. L. (2002). Production and properties of asparaginase from a new Erwinia sp. Folia Microbiologica, 47(5), 473\u2013476.","journal-title":"Folia Microbiologica"},{"issue":"2","key":"9755_CR83","first-page":"277","volume":"35","author":"LA Minim","year":"1992","unstructured":"Minim, L. A., & Alegre, M. (1992). Production of enzyme l-Asparaginase from Erwinia aroideae. Arquivos de Biologia e Tecnologia (Curitiba), 35(2), 277\u2013283.","journal-title":"Arquivos de Biologia e Tecnologia (Curitiba)"},{"issue":"3","key":"9755_CR84","first-page":"212","volume":"21","author":"N Ramaiah","year":"1992","unstructured":"Ramaiah, N., & Chandramohan, D. (1992). Production of l-asparaginase from marine luminous bacteria. Indian Journal of Marine Sciences, 21(3), 212\u2013214.","journal-title":"Indian Journal of Marine Sciences"},{"issue":"1","key":"9755_CR85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1385\/ABAB:135:1:33","volume":"135","author":"A Mishra","year":"2006","unstructured":"Mishra, A. (2006). Production of l-asparaginase, an anticancer agent, from Aspergillus niger using agricultural waste in solid state fermentation. Applied Biochemistry and Biotechnology, 135(1), 33\u201342.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"2","key":"9755_CR86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02881635","volume":"22","author":"J Netrval","year":"1977","unstructured":"Netrval, J. (1977). Stimulation of l-asparaginase production in Escherichia coli by organic and amino acids. Folia Microbiologica, 22(2), 106\u2013116.","journal-title":"Folia Microbiologica"},{"issue":"12","key":"9755_CR87","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0141-0229(89)90054-9","volume":"11","author":"CR Goward","year":"1989","unstructured":"Goward, C. R., Stevens, G. B., Collins, I. J., Wilkinson, I. R., & Scawen, M. D. (1989). Use of macrosorb keiselguhr composite and CM-sepharose fast flow for the large-scale purification of l-asparaginase from Erwinia chrysanthemi. Enzyme and Microbial Technology, 11(12), 810\u2013814.","journal-title":"Enzyme and Microbial Technology"},{"key":"9755_CR88","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.procbio.2009.09.011","volume":"45","author":"S Kumar","year":"2010","unstructured":"Kumar, S., Venkata Dasu, V., & Pakshirajan, K. (2010). Localization and production of novel l-asparaginase from Pectobacterium carotovorum MTCC 1428. Process Biochemistry, 45, 223\u2013229.","journal-title":"Process Biochemistry"},{"issue":"2","key":"9755_CR89","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui, C. H., & Evans, W. E. (2006). Treatment of acute lymphoblastic leukaemia. The New England Journal of Medicine, 354(2), 166\u2013178.","journal-title":"The New England Journal of Medicine"},{"key":"9755_CR90","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood.V99.6.1986","volume":"99","author":"VI Avramis","year":"2002","unstructured":"Avramis, V. I., Sencer, S., Periclou, A. P., Harland, S., Bostrom, B. C., Cohen, L. J., Ettinger, A. G., Ettinger, L. J., Hilden, J. M., Lange, B., Majilessipour, F. A. T., Pracad, M., Needle, M., Nehlia, J., Reaman, G., & Holcenberg, J. S. (2002). A randomized comparison of native E. coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukaemia: a Children\u2019s Cancer Group study. Blood, 99, 1986\u20131994.","journal-title":"Blood"},{"key":"9755_CR91","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2006-07-035006","volume":"109","author":"D Douer","year":"2007","unstructured":"Douer, D., Yampolsky, H., Cohen, L. J., Watkins, K., Levine, A. M., Periclou, A. P., & Avramis, V. I. (2007). Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55\u00a0years or younger with newly diagnosed acute lymphoblastic leukaemia. Blood, 109, 2744\u20132750.","journal-title":"Blood"},{"key":"9755_CR92","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1182\/blood-2006-09-045351","volume":"109","author":"M Wetzler","year":"2007","unstructured":"Wetzler, M., Sanford, B. L., Kurtzberg, J., DeOliveira, D., Frankel, S. R., Powell, B. L., Kolitz, J. E., Bloomfield, C. D., & Larson, R. A. (2007). Effective l-Asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukaemia: Cancer and Leukaemia Group B Study 9511. Blood, 109, 4164\u20134167.","journal-title":"Blood"},{"key":"9755_CR93","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2005-08-3451","volume":"107","author":"ML Loh","year":"2006","unstructured":"Loh, M. L., Goldwasser, M. A., Silverman, L. B., Poon, W. M., Vattikuti, S., Cardoso, A., Neuberq, D. S., Shannon, K. M., & Gilliland, D. G. (2006). Prospective analysis of TEL\/AML1-positive patients treated on Dana\u2013Farber Cancer Institute Consortium Protocol 95-01. Blood, 107, 4508\u20134513.","journal-title":"Blood"},{"key":"9755_CR94","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2002-08-2372","volume":"102","author":"DO Harms","year":"2003","unstructured":"Harms, D. O., Gobel, U., Spaar, H. J., Graubner, U. B., Jorch, N., Gutjahr, P., & Janka-Schaub, G. E. (2003). Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Blood, 102, 2736\u20132740.","journal-title":"Blood"},{"key":"9755_CR95","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.V99.3.825","volume":"99","author":"BJ Lange","year":"2002","unstructured":"Lange, B. J., Bostrom, B. C., Cherlow, J. M., Sensel, M. G., La, M. K., Rackoff, W., Heerema, N. A., Wimmer, R. S., Triqq, M. E., & Sther, H. N. (2002). Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukaemia: a report from the Children\u2019s Cancer Group. Blood, 99, 825\u2013833.","journal-title":"Blood"},{"key":"9755_CR96","first-page":"540","volume":"27","author":"D Hoelzer","year":"2000","unstructured":"Hoelzer, D., & Gokbuget, N. (2000). New approaches to lymphoblastic leukaemia in adults: where do we go? Seminars in Oncology, 27, 540\u2013559.","journal-title":"Seminars in Oncology"},{"key":"9755_CR97","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","volume":"101","author":"H Kantarjian","year":"2004","unstructured":"Kantarjian, H., Thomas, D., O\u2019Brien, S., Cortes, J., Giles, F., Jeha, S., Bueso-Ramos, C. E., Pierce, S., Shan, J., Koller, C., Beran, M., Keatinq, M., & Freireich, E. J. (2004). Long-term follow-up results of hyper fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone [Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukaemia. Cancer, 101, 2788\u20132801.","journal-title":"Cancer"},{"key":"9755_CR98","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2002.07.116","volume":"20","author":"C Linker","year":"2002","unstructured":"Linker, C., Damon, L., Ries, C., & Navarro, W. (2002). Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukaemia. Journal of Clinical Oncology, 20, 2464\u20132471.","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR99","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2008-01-130237","volume":"112","author":"W Stock","year":"2008","unstructured":"Stock, W., La, M., Sanford, B., Bloomfield, C. D., Vardiman, J. W., Gavnon, P., Larson, R. A., & Nachman, J. (2008). What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of children\u2019s cancer group and cancer and leukemia group b studies. Blood, 112, 1646\u20131654.","journal-title":"Blood"},{"key":"9755_CR100","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","volume":"368","author":"A Vora","year":"2006","unstructured":"Vora, A., Mitchell, C. D., Lennard, L., Eden, T. O. B., Kinsey, S. E., Lilleyman, J., & Richards, S. M. (2006). Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet, 368, 1339\u20131348.","journal-title":"Lancet"},{"key":"9755_CR101","first-page":"9","volume":"1","author":"M Nesbit","year":"1979","unstructured":"Nesbit, M., Chard, R., Evans, A., Karon, M., & Hammond, G. D. (1979). Evaluation of intramuscular versus intravenous administration of l-asparaginase in childhood leukemia. The American Journal of Pediatric Hematology\/Oncology, 1, 9\u201313.","journal-title":"The American Journal of Pediatric Hematology\/Oncology"},{"key":"9755_CR102","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","volume":"315","author":"LA Clavell","year":"1980","unstructured":"Clavell, L. A., Gelber, R. D., Cohen, H. J., Hitchcock-Bryan, S., Cassady, J. R., Tarbell, N. J., Blattner, S. R., Tantravahi, R., Leavitt, P., & Sallan, S. E. (1980). Four-agent induction and intensive l-asparaginase therapy for treatment of childhood acute lymphoblastic leukaemia. New England Journal of Medicine, 315, 657\u2013663.","journal-title":"New England Journal of Medicine"},{"key":"9755_CR103","first-page":"693","volume":"141","author":"S Desai","year":"1989","unstructured":"Desai, S., Barr, R., Andrew, M., deVeber, L., & Pai, M. (1989). Management of Ontario children with acute lymphoblastic leukaemia by the Dana\u2013Farber Cancer Institute Protocols. Canadian Medical Association Journal, 141, 693.","journal-title":"Canadian Medical Association Journal"},{"key":"9755_CR104","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.1997.15.6.2222","volume":"15","author":"J Nachman","year":"1997","unstructured":"Nachman, J., Sather, H. N., Gaynon, P. S., Lukens, J. N., Wolff, L., & Trigg, M. E. (1997). Augmented Berlin\u2013Frankfurt\u2013Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy of children and adolescents with acute lymphoblastic leukaemia and unfavourable presenting features: a report from children\u2019s Cancer Group. Journal of Clinical Oncology, 15, 222\u2013230.","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1701223","volume":"21","author":"ML Grahm","year":"1998","unstructured":"Grahm, M. L., Asselin, B. L., Herndon, J. E., Casey, J. R., Chaffee, S., Cioccci, G. H., Daeschner, C. W., Davis, A. R., Gold, S., Halperin, E. C., Laughlin, M. J., Martin, P. L., Olson, J. F., & Kurtzberg, J. (1998). Toxicity, pharmacology and feasibility of administration of PEG-l-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplantation, 21, 879\u2013885.","journal-title":"Bone Marrow Transplantation"},{"key":"9755_CR106","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","volume":"282","author":"HJ Muller","year":"1998","unstructured":"Muller, H. J., & Boos, J. (1998). Use of l-asparaginase in childhood ALL. Critical Reviews in Oncology\/Hematology, 282, 97\u2013113.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"9755_CR107","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","volume":"13","author":"MD Amylon","year":"1999","unstructured":"Amylon, M. D., Shuster, J., & Ja, P. (1999). Intensive high-dose asparaginase consolidation improves survival for paediatric patients with T-cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Paediatric Oncology Group study. Leukemia, 13, 335\u2013342.","journal-title":"Leukemia"},{"key":"9755_CR108","first-page":"5601","volume":"43","author":"SE Sallan","year":"1983","unstructured":"Sallan, S. E., Hitchcock-Bryan, S., & Gelber, R. (1983). Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukaemia. Cancer Research, 43, 5601\u20135607.","journal-title":"Cancer Research"},{"key":"9755_CR109","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood.V96.5.1709","volume":"96","author":"TC Abshire","year":"2000","unstructured":"Abshire, T. C., Pollock, B. H., Billett, A. L., Bradley, P., & Buchanan, G. R. (2000). Weekly polyethylene glycol conjugated l-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukaemia: a Pediatric Oncology Group Study. Blood, 96, 1709\u20131715.","journal-title":"Blood"},{"key":"9755_CR110","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","volume":"23","author":"A Pession","year":"2005","unstructured":"Pession, A., Valsecchi, M. G., Masera, G., Kamps, W. A., Magyarosy, E., Rizzari, C., Van Wering, E. R., Lo Nigro, L., Vander Does, A., Locatelli, F., Basso, G., & Arico, M. (2005). Long-term results of a randomized trial on extended use of high dose l-asparaginase for standard risk childhood acute lymphoblastic leukaemia. Journal of Clinical Oncology, 23, 7161\u20137167.","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR111","doi-asserted-by":"crossref","unstructured":"Moghrabi, A., Levy, D. E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V. K., Lipshultz, S. E., Neuberg, D. S., Gelber, D. R., Cohen, H. J., Sallan, S. E., & Silverman, L. B. (2007). Results of the Dana\u2013Farber Cancer Institute ALL Consortium Protocol 95\u201301 for children with acute lymphoblastic leukaemia. Blood, 109, 896\u2013904.","DOI":"10.1182\/blood-2006-06-027714"},{"key":"9755_CR112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00043426-199901000-00003","volume":"21","author":"BL Asselin","year":"1999","unstructured":"Asselin, B. L., Kreissman, S., Coppola, D. J., Bernal, S. D., Leavitt, P. R., Gelber, R. D., Sallan, S. E., & Cohen, H. J. (1999). Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukaemia. Journal of Pediatric Hematology\/Oncology, 21, 6\u201312.","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"9755_CR113","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1107\/S1744309105008249","volume":"61","author":"LE Wikman","year":"2005","unstructured":"Wikman, L. E., Krasotkina, J., Kuchumova, A., Sokolov, N. N., & Papageorgiou, A. C. (2005). Crystallization and preliminary crystallographic analysis of l-Asparaginase from Erwinia carotovora. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications, 61, 407\u2013409.","journal-title":"Acta Crystallographica. Section F, Structural Biology and Crystallization Communications"},{"key":"9755_CR114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-4838(01)00270-9","volume":"1550","author":"K Aghaiypour","year":"2001","unstructured":"Aghaiypour, K., Wlodawer, A., & Lubkowski, J. (2001). Do bacterial l-asparaginases utilize a catalytic triad Thr\u2013Tyr\u2013Glu? Biochimica et Biophysica Acta, 1550, 117\u2013128.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9755_CR115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-4838(01)00270-9","volume":"1550","author":"K Aghaiypour","year":"2001","unstructured":"Aghaiypour, K., Wlodawer, A., & Lubkowski, J. (2001). Do bacterial l-asparaginases utilize a catalytic triad Thr\u2013Tyr\u2013Glu? Biochemica et Biophysica Acta, 1550, 117\u2013128.","journal-title":"Biochemica et Biophysica Acta"},{"key":"9755_CR116","unstructured":"Jackson, R. D., Handschumacher, R. E. (1970). E. coli l-asparaginase: catalytic activity and subunit nature. Biochem."},{"key":"9755_CR117","unstructured":"Harrison, P. L., Wang, B., Pui, C.-H., Relling, M. V. Cerebrospiistry, 9:3585\u20133590"},{"key":"9755_CR118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/bchm2.1980.361.1.105","volume":"361","author":"T Maita","year":"1980","unstructured":"Maita, T., & Matsuda, G. (1980). The primary structure of l-asparaginase from Escherichia coli. Hoppe-Seyler\u2019s Z Physiol Chem, 361, 105\u2013117.","journal-title":"Hoppe-Seyler\u2019s Z Physiol Chem"},{"key":"9755_CR119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1107\/S0907444901016663","volume":"58","author":"M Kozak","year":"2002","unstructured":"Kozak, M., Borek, D., Janowski, R., & Jaskolski, M. (2002). Crystallization and preliminary crystallographic studies of negative crystal forms of Escherichia coli l-asparaginase II [Asp90Glu mutant). Acta Crystallographica Section D Biological Crystallography, 58, 130\u2013132.","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"9755_CR120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2795(69)90191-3","volume":"194","author":"J Kirchbaum","year":"1969","unstructured":"Kirchbaum, J., Wriston, J. C., & Ratych, O. T. (1969). Subunit structure of asparaginase from Escherichia coli B. Biochimica et Biophysica Acta Protein Structure, 194, 161\u2013169.","journal-title":"Biochimica et Biophysica Acta Protein Structure"},{"key":"9755_CR121","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1016\/S0021-9258(19)45833-X","volume":"246","author":"S Shifrin","year":"1971","unstructured":"Shifrin, S., Luborsky, S. W., & Grochowski, B. J. (1971). l-Asparaginase from Escherichia coli B. Physicochemical studies of the dissociation process. Journal of Biological Chemistry, 246, 7708\u20137714.","journal-title":"Journal of Biological Chemistry"},{"key":"9755_CR122","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mpo.2950180612","volume":"18","author":"OB Eden","year":"1990","unstructured":"Eden, O. B., Shaw, M. P., Lilleyman, J. S., & Richards, S. (1990). Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia. Medical and Pediatric Oncology, 18, 497\u2013502.","journal-title":"Medical and Pediatric Oncology"},{"key":"9755_CR123","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1107\/S0021889893005588","volume":"26","author":"W Kabsch","year":"1993","unstructured":"Kabsch, W. (1993). Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. Journal of Applied Crystallography, 26, 795\u2013800.","journal-title":"Journal of Applied Crystallography"},{"key":"9755_CR124","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.1995.tb00699.x","volume":"55","author":"H Carlsson","year":"1995","unstructured":"Carlsson, H., Stockelberg, D., Tengborn, L., Braide, I., Carneskog, J., & Kutti, J. (1995). Effects of Erwinia-asparaginase on the coagulation system. European Journal of Haematology, 55, 289\u2013293.","journal-title":"European Journal of Haematology"},{"key":"9755_CR125","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","volume":"21","author":"JM Goldberg","year":"2003","unstructured":"Goldberg, J. M., Silverman, L. B., Levy, D. E., Dalton, V. K., Gelber, R. D., Lehmann, L., Cohen, H. J., Sallan, S. E., & Asselin, B. L. (2003). Childhood T-cell acute lymphoblastic leukaemia: the Dana\u2013Farber Cancer Institute acute lymphoblastic leukaemia consortium experience. Journal of Clinical Oncology, 21, 3616\u20133622.","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR126","first-page":"241","volume":"1","author":"VI Avramis","year":"2006","unstructured":"Avramis, V. I., & Tiwari, P. N. (2006). Asparaginase [native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukaemia. International Journal of Nanomedicine, 1, 241\u2013254.","journal-title":"International Journal of Nanomedicine"},{"key":"9755_CR127","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/pbc.20406","volume":"46","author":"JP Vieira Pinheiro","year":"2006","unstructured":"Vieira Pinheiro, J. P., Wenner, K., Escherich, G., Lanvers-Kaminsky, C., Wurthwein, G., Janka-Schaub, G., & Boos, J. (2006). Serum asparaginase activities and asparagine concentrations in the cerebrospinal fluid after a single infusion of 2,500\u00a0IU\/m2 PEG asparaginase in children with ALL treated according to protocol COALL-06-97. Pediatric Blood & Cancer, 46, 18\u201325.","journal-title":"Pediatric Blood & Cancer"},{"key":"9755_CR128","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.critrevonc.2006.07.009","volume":"61","author":"UK Narta","year":"2007","unstructured":"Narta, U. K., Kanwar, S. S., & Azmi, W. (2007). Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia. Critical Reviews in Oncology\/Hematology, 61, 208\u2013221.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"9755_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1107\/S090744490603575X","volume":"63","author":"J Janin","year":"2007","unstructured":"Janin, J., Rodier, F., Chakrabarti, P., & Bahadur, R. (2007). Macromolecular recognition in the Protein Data Bank. Acta Crystallographica. Section D, Biological Crystallography, 63, 1\u20138.","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"9755_CR130","first-page":"373","volume":"1","author":"YK Park","year":"1981","unstructured":"Park, Y. K., Abuchowski, A., Davis, S., & Davis, F. (1981). Pharmacology of E. coli l-asparaginase polyethylene glycols adduct. Anticancer Research, 1, 373\u2013376.","journal-title":"Anticancer Research"},{"key":"9755_CR131","first-page":"219","volume":"9","author":"J Kurtzberg","year":"1990","unstructured":"Kurtzberg, J., Friedman, H., Asselin, B., et al. (1990). The use of polyethylene glycol-conjugated l-asparaginase [PEG-Asp) in paediatric patients with prior hypersensitivity to native l-asparaginase. American Society of Clinical Oncology, 9, 219.","journal-title":"American Society of Clinical Oncology"},{"key":"9755_CR132","unstructured":"Ettinger, L., Asselin, B., Poplack, D., Kurtzberg, J. (1993). Toxicity profile of PEG- l-asparaginase in native l-asparaginase-hypersensitive and non hypersensitive patients with acute lymphoblastic leukaemia (ALL). Presented at international Society of Paediatric Oncology [SIOP) 25th meeting."},{"key":"9755_CR133","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","volume":"54","author":"MJ Roberts","year":"2002","unstructured":"Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002). Chemistry for peptide and protein PEGylation. Advanced Drug Delivery Reviews, 54, 459\u2013476.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"9755_CR134","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0149-2918(02)80075-3","volume":"24","author":"H Schellekens","year":"2002","unstructured":"Schellekens, H. (2002). Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clinical Therapeutics, 24, 1720\u20131740.","journal-title":"Clinical Therapeutics"},{"key":"9755_CR135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","volume":"83","author":"L Mitchell","year":"1994","unstructured":"Mitchell, L., Hoogendoorn, H., Giles, A. R., Vegh, P., & Andrew, M. (1994). Increased endogenous thrombin generation in children with acute lymphoblastic leukaemia: risk of thrombotic complications in l-asparaginase-induced antithrombin III deficiency. Blood, 83, 386.","journal-title":"Blood"},{"key":"9755_CR136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.1992.tb00032.x","volume":"49","author":"L Gugliotta","year":"1992","unstructured":"Gugliotta, L., Mazzucconi, M. G., Leone, G., Mattioli-Belmonte, M., Defazio, D., Annino, L., Tura, S., Mandelli, F., & the GIMEMA Group. (1992). Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving l-asparaginase during induction therapy: a retrospective study. European Journal of Haematology, 49, 63.","journal-title":"European Journal of Haematology"},{"key":"9755_CR137","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0609.1980.tb02359.x","volume":"24","author":"E Andersen","year":"1980","unstructured":"Andersen, E., & Videbaek, A. (1980). Procarbazine-induced skin reactions in Hodgkin\u2019s disease and other malignant lymphomas. Scandinavian Journal of Haematology, 24, 149\u2013151.","journal-title":"Scandinavian Journal of Haematology"},{"key":"9755_CR138","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/1097-0142(19801001)46:7<1548::AID-CNCR2820460709>3.0.CO;2-7","volume":"46","author":"JR Priest","year":"1980","unstructured":"Priest, J. R., Ramsay, N. K. C., Latchaw, R. E., Lockman, L. A., Hasegawa, D. K., Coates, T. D., Coccia, P. F., Edson, J. R., Nesbit, M. E., & Krivit, W. (1980). Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer, 46, 1548\u20131554.","journal-title":"Cancer"},{"key":"9755_CR139","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.1987.5.5.811","volume":"5","author":"AC Homans","year":"1987","unstructured":"Homans, A. C., Ryback, M. E., Baglini, R. L., Tiarks, C., Steiner, M. E., & Forman, E. N. (1987). Effect of l-Asparginase administration on coagulation and platelet function in children with leukemia. Journal of Clinical Oncology, 5, 811\u2013817.","journal-title":"Journal of Clinical Oncology"},{"key":"9755_CR140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000206887","volume":"69","author":"T Barbui","year":"1983","unstructured":"Barbui, T., Rodeghiero, F., Meli, S., & Dini, E. (1983). Fatal pulmonary embolism and antithrombin 111 deficiency in adult lymphoblastic leukemia during l-asparaginase therapy. Acta Haematologica, 69, 188.","journal-title":"Acta Haematologica"},{"key":"9755_CR141","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0049-3848(90)90122-S","volume":"59","author":"S Vigano-DAngelo","year":"1990","unstructured":"Vigano-DAngelo, S., Gugliotta, L., Mattioli, B., Cascione, M. L., Pattarina, E., & D\u2019Angelo, A. (1990). l-Asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation. Thrombosis Research, 59, 985.","journal-title":"Thrombosis Research"},{"issue":"8","key":"9755_CR142","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.mcg.0000173929.60115.b4","volume":"39","author":"CD Trivedi","year":"2005","unstructured":"Trivedi, C. D., & Pitchumoni, C. S. (2005). Drug induced pancreatitis: an update. Journal of Clinical Gastroenterology, 39(8), 709\u2013716.","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"9755_CR143","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.dld.2004.05.016","volume":"37","author":"CA Aoki","year":"2005","unstructured":"Aoki, C. A., Bowlus, C. L., & Rossaro, L. (2005). An adult case of acute lymphoblastic leukemia presenting as hepatic dysfunction. Digestive and Liver Disease, 37(3), 206\u2013210.","journal-title":"Digestive and Liver Disease"},{"issue":"5","key":"9755_CR144","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jpeds.2004.12.043","volume":"146","author":"DH Brodtman","year":"2005","unstructured":"Brodtman, D. H., Rosenthal, D. W., Redner, A., Lanzkowsky, P., & Bonagura, V. R. (2005). Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. Journal of Pediatrics, 146(5), 654\u2013661.","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"9755_CR145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2003-42647","volume":"23","author":"S Sahoo","year":"2003","unstructured":"Sahoo, S., & Hart, J. (2003). Histopathological features of l-asparaginase induced liver disease. Seminars in Liver Disease, 23(3), 295\u2013299.","journal-title":"Seminars in Liver Disease"},{"issue":"5","key":"9755_CR146","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/10428190500052206","volume":"46","author":"T Imamura","year":"2005","unstructured":"Imamura, T., Morimoto, A., Kato, R., Izumi, M., Murakami, A., Matuo, S., Kivosawa, N., Kano, G., Yoshioka, H., Sugimoto, T., & Imashuku, S. (2005). Cerebral thrombotic complications in adolescent leukemia\/lymphoma patients treated with l-asparaginase containing chemotherapy. Leukemia & Lymphoma, 46(5), 729\u2013735.","journal-title":"Leukemia & Lymphoma"},{"issue":"2","key":"9755_CR147","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.20485","volume":"46","author":"TB Haddy","year":"2006","unstructured":"Haddy, T. B., Mosher, R. B., Nunez, S. B., & Reaman, G. H. (2006). Growth hormone deficiency after chemotherapy for acute lymphoblastic leukaemia in children who have not received cranial radiation. Pediatric Blood & Cancer, 46(2), 258\u2013261.","journal-title":"Pediatric Blood & Cancer"},{"key":"9755_CR148","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2353\/ajpath.2006.051238","volume":"169","author":"D Hern\u00e1ndez-Espinosa","year":"2006","unstructured":"Hern\u00e1ndez-Espinosa, D., Minano, A., Martinez, C., P\u00e9rez-Ceballos, E., Heras, I., Fuster, J. L., Vicente, F. V., & Corral, J. (2006). l-Asparaginase-induced antithrombin type I deficiency. American Journal of Pathology, 169, 142\u2013153.","journal-title":"American Journal of Pathology"},{"issue":"2","key":"9755_CR149","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","volume":"83","author":"L Mitchell","year":"1994","unstructured":"Mitchell, L., Hoogendoorn, H., & Giles, A. R. (1994). Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in l-asparaginase induced antithrombin III deficiency. Blood, 83(2), 386\u2013391.","journal-title":"Blood"},{"issue":"2","key":"9755_CR150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4321\/S1885-642X2006000200001","volume":"4","author":"AE Omoti","year":"2006","unstructured":"Omoti, A. E., & Omoti, C. E. (2006). Ocular toxicity of systemic anticancer chemotherapy. Pharmacy Practice, 4(2), 55\u201359.","journal-title":"Pharmacy Practice"},{"issue":"1","key":"9755_CR151","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.0902-4441.2004.00173.x","volume":"72","author":"A Saviola","year":"2004","unstructured":"Saviola, A., Luppi, M., Potenza, L., Morselli, M., Bresciani, P., Ferrari, A., Riva, G., & Torelli, G. (2004). Myocardial ischemia in a patient with acute lymphoblastic leukemia during l-asparaginase therapy. European Journal of Haematology, 72(1), 71\u201372.","journal-title":"European Journal of Haematology"},{"key":"9755_CR152","first-page":"535","volume":"37","author":"JA Ortega","year":"1977","unstructured":"Ortega, J. A., Nesbit, M. E., & Donaldson, M. H. (1977). l-Asparaginase, vincristine and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Research, 37, 535\u2013540.","journal-title":"Cancer Research"},{"key":"9755_CR153","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/1097-0142(1971)28:4<819::AID-CNCR2820280403>3.0.CO;2-9","volume":"28","author":"WW Sutow","year":"1971","unstructured":"Sutow, W. W., Garcia, F., & Starling, K. A. (1971). l-Asparaginase therapy in children with advanced leukemia. Cancer, 28, 819\u2013824.","journal-title":"Cancer"},{"issue":"5","key":"9755_CR154","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1271\/bbb1961.35.743","volume":"35","author":"N Nakamura","year":"1971","unstructured":"Nakamura, N., Marikina, Y., & Tanaka, M. (1971). l-Asparaginase from E. coli: Part II. Substrate specificity studies. Agricultural and Biological Chemistry, 35(5), 743\u2013751.","journal-title":"Agricultural and Biological Chemistry"},{"key":"9755_CR155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-U","volume":"25","author":"HF Oettgen","year":"1970","unstructured":"Oettgen, H. F., Stephenson, P. A., Schwartz, M. K., Leeper, R. D., Tallal, L., Tan, C. C., Clarkson, B. D., Golbey, R. B., Krakoff, I. H., Karnofsky, D. A., Murphy, L., Burchenal, J. H., et al. (1970). Toxicity of E. coli l-asparaginase in man. Cancer, 25, 253\u2013278.","journal-title":"Cancer"},{"key":"9755_CR156","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000175354","volume":"13","author":"N Zollner","year":"1971","unstructured":"Zollner, N., & Heimstadt, P. (1971). Effects of a single administration of l-asparaginase on serum lipids. Nutrition and Metabolism, 13, 344.","journal-title":"Nutrition and Metabolism"},{"key":"9755_CR157","first-page":"55","volume":"37","author":"MC Favrot","year":"1983","unstructured":"Favrot, M. C., Dallamonica, C., & Soullet, G. (1983). Study of blood lipids in 30 children with a malignant hematological disease or carcinoma. Biomedicine & Pharmacotherapy, 37, 55.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"9755_CR158","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/1097-0142(19941215)74:12<3234::AID-CNCR2820741224>3.0.CO;2-1","volume":"74","author":"PG Steinherz","year":"1994","unstructured":"Steinherz, P. G. (1994). Transient, severe hyperlipidemia in patients with acute lymphoblastic leukaemia treated with prednisone and asparaginase. Cancer, 74, 3234.","journal-title":"Cancer"},{"issue":"4","key":"9755_CR159","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/annonc\/mdg154","volume":"14","author":"B Meyer","year":"2003","unstructured":"Meyer, B., Hagen, W., Scheithauer, W., Ohler, L., & Kornek, G. V. (2003). l-Asparaginase-associated hyperlipidemia with hyperviscosity syndrome in a patient with T-cell lymphoblastic. Annals of Oncology, 14(4), 658\u2013659.","journal-title":"Annals of Oncology"},{"key":"9755_CR160","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood.V89.6.1886","volume":"6","author":"SK Parsons","year":"1997","unstructured":"Parsons, S. K., Skapek, S. X., Neufeld, E. J., Kuhlman, C., Young, M. L., Donnelly, M., Brunzell, J. D., Otvos, J. D., Sallan, S. E., & Rifai, N. (1997). Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood, 6, 1886\u20131895.","journal-title":"Blood"},{"key":"9755_CR161","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/1097-0142(197208)30:2<339::AID-CNCR2820300206>3.0.CO;2-P","volume":"30","author":"VJ Land","year":"1972","unstructured":"Land, V. J., Sutow, W. W., Fernbach, D. J., Lane, D. M., & Williams, T. E. (1972). Toxicity of l-asparaginase in children with advanced leukemia. Cancer, 30, 339\u2013347.","journal-title":"Cancer"},{"key":"9755_CR162","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-U","volume":"25","author":"HF Oettgen","year":"1970","unstructured":"Oettgen, H. F., Stephenson, P. A., Schwartz, M. K., Leeper, R. D., Tallai, L., Tan, C. C., Clarkson, B. D., Golbey, R. B., Krakoff, I. H., Karnofsky, D. A., Murphy, M. L., & Borchenal, J. H. (1970). Toxicity of E. coli l-asparaginase in man. Cancer, 25, 253.","journal-title":"Cancer"},{"key":"9755_CR163","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.1969.03160360065021","volume":"210","author":"T Ohnuma","year":"1969","unstructured":"Ohnuma, T., Holland, J. F., Nagal, G., & St. Arneault, G. (1969). Effects of l-asparaginase in acute myelocytic leukemia. Journal of the American Medical Association, 210, 1919\u20131921.","journal-title":"Journal of the American Medical Association"},{"key":"9755_CR164","first-page":"161","volume":"15","author":"D Gonz\u00e1lez","year":"2000","unstructured":"Gonz\u00e1lez, D., Salazar Saez, R., Moreno Rodilla, E., Laffond Yges, Y. E., & Lorente Toledano, F. (2000). Hypersensitivity reactions to chemotherapy drugs. Clinical Reviews in Allergy & Immunology, 15, 161\u2013181.","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"9755_CR165","first-page":"325","volume":"135","author":"D Korholz","year":"1987","unstructured":"Korholz, D., Urbanek, R., Nurnberger, W., Jobke, A., Gobel, U., & Wahn, V. (1987). Formation of specific IgG antibodies in l-asparaginase treatment. Distribution of IgG subclasses. Monatsschrift Kinderheilkunde, 135, 325\u2013328.","journal-title":"Monatsschrift Kinderheilkunde"},{"issue":"10","key":"9755_CR166","first-page":"476","volume":"95","author":"F Rossi","year":"2004","unstructured":"Rossi, F., Incorvaia, C., & Mauro, M. (2004). Hypersenstivity reactions to chemotherapeutic antineoplastic agents. Recenti Progressi in Medicina, 95(10), 476\u2013481.","journal-title":"Recenti Progressi in Medicina"},{"key":"9755_CR167","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/BA20030138","volume":"39","author":"J Krasotkina","year":"2004","unstructured":"Krasotkina, J., Borisova, A. A., Gervaziew, Y. V., & Sokolov, N. N. (2004). One-Step Purification and kinetic properties of the recombinant l-Asparaginase from Erwinia carotovora. Biotechnology and Applied Biochemistry, 39, 215\u2013221.","journal-title":"Biotechnology and Applied Biochemistry"},{"key":"9755_CR168","first-page":"248","volume":"D64","author":"OV Kravchenko","year":"2008","unstructured":"Kravchenko, O. V., Kislitsin, Yu. A., Popov, A. N., Nikonov, S. V., & Kuranova, I. P. (2008). Three-dimensional structures of l-asparaginase from Erwinia carotovora complexed with aspartate and glutamate. Acta Crystallographica, D64, 248\u2013256.","journal-title":"Acta Crystallographica"},{"key":"9755_CR169","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2362.1988.tb01049.x","volume":"18","author":"G Ollenschlager","year":"1988","unstructured":"Ollenschlager, G., Roth, E., Linkesch, W., Jansen, S., Simmel, A., & Modder, B. (1988). Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects. European Journal of Clinical Investigation, 18, 512\u2013516.","journal-title":"European Journal of Clinical Investigation"},{"key":"9755_CR170","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1110\/ps.9.10.2009","volume":"9","author":"C Derst","year":"2000","unstructured":"Derst, C., Henseling, J., & R\u00f6hm, K. H. (2000). Engineering the substrate specificity of Escherichia coli asparaginase: II. Selective reduction of glutaminase activity by amino acid replacements at position 248. Protein Science, 9, 2009\u20132017.","journal-title":"Protein Science"},{"key":"9755_CR171","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00253-009-1973-0","volume":"84","author":"S Kumar","year":"2009","unstructured":"Kumar, S., Pakshirajan, K., & Venkata Dasu, V. (2009). Development of medium for enhanced production of glutaminase-free l-asparaginase from Pectobacterium carotovorum MTCC 1428. Applied Microbiology and Biotechnology, 84, 477\u2013486.","journal-title":"Applied Microbiology and Biotechnology"},{"key":"9755_CR172","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12010-010-9041-x","volume":"163","author":"S Kumar","year":"2010","unstructured":"Kumar, S., Pakshirajan, K., & Venkata Dasu, V. (2010). Assessment of physical process conditions for enhanced production of novel glutaminase-free l-Asparaginase from Pectobacterium carotovorum MTCC 1428. Applied Biochemistry and Biotechnology, 163, 327\u2013337.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"9755_CR173","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00295504","volume":"30","author":"S Manna","year":"1995","unstructured":"Manna, S., Sinha, A., Sadhukhan, R., & Chakrabarty, S. L. (1995). Purification, characterization and antitumor activity of l-asparaginase isolated from Pseudomonas stutzeri MB-405. Current Microbiology, 30, 291\u2013298.","journal-title":"Current Microbiology"},{"issue":"8","key":"9755_CR174","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/MPH.0b013e31822aa4ec","volume":"33","author":"LN Ramya","year":"2011","unstructured":"Ramya, L. N., Doble, M., Rekha, V. P. B., & Pulicherla, K. K. (2011). In silico engineering of l-Asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukaemia. Journal of Pediatric Hematology\/Oncology, 33(8), 617\u2013621.","journal-title":"Journal of Pediatric Hematology\/Oncology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-012-9755-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-012-9755-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-012-9755-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T02:12:13Z","timestamp":1642385533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-012-9755-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,9]]},"references-count":174,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["9755"],"URL":"https:\/\/doi.org\/10.1007\/s12010-012-9755-z","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,9]]}}}